Alnylam Pharmaceuticals, Inc. (ALNY)
320.47
-6.83
(-2.09%)
USD |
NASDAQ |
Mar 05, 16:00
319.77
-0.70
(-0.22%)
After-Hours: 19:45
Alnylam Pharmaceuticals EPS Diluted from Tax Loss Carryforward (Quarterly)
EPS Diluted from Tax Loss Carryforward (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted from Tax Loss Carryforward (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted from Tax Loss Carryforward (Quarterly) Benchmarks
| Insmed, Inc. | -- |
| Biogen, Inc. | -- |
| Pfizer Inc. | -- |
| Eli Lilly & Co. | -- |
| AbbVie, Inc. | -- |